Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Crit Care Med. 2022 Feb 1;50(2):173–182. doi: 10.1097/CCM.0000000000005393

Figure 1. Multivariable analysis of clinical factors related to delirium/coma development within 3 days following red blood cell transfusion.

Figure 1.

This Forest plot demonstrates increased risk for delirium/coma in transfused patients who had altered cognitive status (as measured by existing delirium or coma at time of transfusion), and/or exposure to opiates and benzodiazepines. However, there was no independent relationship between the storage-age of the transfused blood and subsequent delirium/coma. Analyses were adjusted for patient age and existing organ dysfunction (as measured by the PELOD-2) at time of transfusion.

[PELOD: pediatric logistic organ dysfunction; RBC: red blood cells].